Givaudan (GIVN) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
29 Aug, 2026Who we are
Operates in over 167 locations worldwide, with 77 production sites and 65 research centers.
Employs more than 17,500 people, speaking over 100 languages.
Over 40% of employees are engaged in future-oriented initiatives such as research and innovation.
Business activities
Two main segments: Taste & Wellbeing and Fragrance & Beauty, serving evolving consumer needs.
Taste & Wellbeing covers savoury, beverages, sweet goods, and dairy, with a focus on innovation and health.
Fragrance & Beauty includes consumer products, fine fragrance, and active beauty solutions.
Portfolio is naturally hedged across geographies and product categories, with balanced sales in mature and high-growth markets.
Innovation and technology
Invested CHF 551 million in R&D in 2025, representing 7.4% of sales, with over 5,000 active patents.
Utilizes AI, digital tools, and automation for product creation, consumer insights, and supply chain optimization.
Focuses on sustainable and natural ingredients, green chemistry, and biotechnology.
Latest events from Givaudan
- Strong sales growth and strategic focus position the company to achieve ambitious 2030 targets.GIVN
Investor presentation - Sales up 3.6% LFL to CHF 3,799m, net income CHF 475m, outlook targets 4–6% LFL growth.GIVN
Q2 2026 - Q1 2026 sales rose 2.8% LFL, led by Fragrance & Beauty, despite currency and cost pressures.GIVN
Q1 2026 TU - Strong 2025 growth, innovation, and sustainability drive robust financial and operational results.GIVN
Investor presentation - Strong 2025 growth, resilient margins, and ambitious sustainability targets drive future strategy.GIVN
Investor presentation - 5.1% LFL sales growth, CHF 1,071m net income, and 25th consecutive dividend increase.GIVN
H2 2025 - Sales up 6.3% LFL, EBITDA margin 25.2%, net income CHF 592m, free cash flow negative.GIVN
H1 2025 - Double-digit sales and profit growth, margin expansion, and new CFO mark a strong half-year.GIVN
H1 2024 - Double-digit sales and profit growth, led by high-growth markets and a record dividend increase.GIVN
H2 2024